COLD-fX

DIETARY_SUPPLEMENT2 trials

Sponsors

Capital Health, Canada, Afexa Life Sciences Inc

Conditions

Respiratory Tract InfectionSeasonal Allergic Rhinitis

Phase 2

A Randomized, Double-blind, Placebo-controlled Study on the Effect of CVT-E002 in Patients With Seasonal Allergic Rhinitis

CompletedNCT00726401

Afexa Life Sciences IncSeasonal Allergic Rhinitis

Start: 2008-05-31End: 2010-09-30Target: 200Updated: 2010-10-11

Phase 3

Use of COLD-fX to Prevent Respiratory Infections in Community Dwelling Seniors

CompletedNCT00240461

Capital Health, CanadaRespiratory Tract Infection

Start: 2005-09-30End: 2008-12-31Updated: 2011-07-07